Q&A | Published:

In dialogue with the NIH on clinical trials policy

Nature Human Behaviourvolume 2pages100102 (2018) | Download Citation

In his capacity as immediate past president of the Federation of Associations of Behavioral and Brain Sciences, Jeremy Wolfe interviews Mike Lauer about the new NIH clinical trials policy. Mike Lauer is NIH’s deputy director for extramural research, serving as the principal scientific leader and advisor to the NIH director on the extramural research programme.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Author information


  1. Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    • Jeremy M. Wolfe


  1. Search for Jeremy M. Wolfe in:

Competing interests

J.M.W. is currently funded by the NIH. He does not have any current advisory role with the NIH though he has previously served as a grant reviewer and study section member. He has no involvement in setting the clinical trial policy changes or their implementation.

Corresponding author

Correspondence to Jeremy M. Wolfe.

About this article

Publication history




Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing